Last year, the Food and Drug Administration approved Shingrix, a Shingles vaccine found to be more effective than Zostavax. All of CVS’ pharmacy locations now carry the vaccine, with the exception of those located in Florida, due to state regulations.
Shingrix is covered by many insurers and it is the recommended vaccine for adults over 50, who should get two doses, two to six months apart. Adults who have already received Zostavax should wait at least eight weeks before receiving the new vaccine.
The risk getting shingles–a painful rash that develops on one side of the face or body that can take two to four weeks to clear–increases with age, according to the Centers for Disease Control. One out of every three people will develop shingles in their lifetime. Anyone who has recovered from chickenpox may develop shingles.